Real-world application of amikacin liposome inhalation in managing complex mycobacterium avium pulmonary conditions

被引：0
|
作者：
Yanagihara, Toyoshi [1 ]
Mori, Asami [2 ]
Ogata, Hiroaki [1 ]
Kadowaki, Masako [3 ]
Moriuchi, Yuki [1 ]
Ishimatsu, Akiko [1 ]
Otsuka, Junji [1 ]
Taguchi, Kazuhito [1 ]
Moriwaki, Atsushi [1 ]
Yoshida, Makoto [1 ]
机构：
[1] NHO Fukuoka Natl Hosp, Dept Resp Med, Fukuoka, Japan
[2] NHO Fukuoka Natl Hosp, Dept Pharm, Fukuoka, Japan
[3] NHO Fukuoka Natl Hosp, Dept Infect Dis, Fukuoka, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP15-006
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [31] Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use (vol 41, pg 405, 2021)
    Hoy, Sheridan M.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 591 - 591
  • [32] A Retrospective Analysis to Assess the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Puc, M.
    Koerner, P.
    Russian, A.
    Faris, R.
    Vanscoy, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) ADDED TO COMBINATION REGIMEN ON RECURRENCE IN NEWLY DIAGNOSED OR RECURRENT MYCOBACTERIUM AVIUM COMPLEX (MAC): THE ARISE STUDY
    van Ingen, Jakko
    Terschlusen, Eva
    Yuen, Dayton
    May, Daniel
    Nevoret, Marie-Laure
    Ciesielska, Monika
    Stein, Daniel
    Mange, Kevin
    CHEST, 2024, 166 (04) : 995A - 996A
  • [34] Phenotypic amikacin resistance may not indicate poor response to amikacin in Mycobacterium avium complex pulmonary disease
    Minuk, L. M.
    Brode, S. K.
    Mehrabi, M.
    Sharma, M. K.
    Stobart, M.
    Soualhine, H.
    Marras, T. K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (06)
  • [35] Reduction in Hospitalizations Following Initiation of Amikacin Liposome Inhalation Suspension: A Retrospective Cohort Study of Patients in Real-World Settings
    Wu, J.
    Hassan, M.
    Cyhaniuk, A.
    Margiotta, C.
    Ratiu, A.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [36] Amikacin Liposome Inhalation Solution (ALIS) for Treatment Refractory Pulmonary Mycobacterium Avium Complex; A Report of the First 50 Patients Who Have Received ALIS and Their Tolerance in a Tertiary Referral Center
    Kasperbauer, S. H.
    Levin, A. R.
    Huitt, G. A.
    Daley, C. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
    Griffith, David E.
    Thomson, Rachel
    Flume, Patrick A.
    Aksamit, Timothy R.
    Field, Stephen K.
    Addrizzo-Harris, Doreen J.
    Morimoto, Kozo
    Hoefsloot, Wouter
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Winthrop, Kevin L.
    CHEST, 2021, 160 (03) : 831 - 842
  • [38] AMIKACIN-INDUCED HYPERSENSITIVITY PNEUMONITIS IN A PATIENT WITH PULMONARY MYCOBACTERIUM AVIUM COMPLEX INFECTION
    Graziani, Casey
    Jiwani, Ali
    CHEST, 2021, 160 (04) : 1166A - 1166A
  • [39] ACTIVITY OF AMIKACIN AGAINST MYCOBACTERIUM-AVIUM COMPLEX UNDER SIMULATED INVIVO CONDITIONS
    GANGADHARAM, PRJ
    KESAVALU, L
    RAO, PNR
    PERUMAL, VK
    ISEMAN, MD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) : 886 - 889
  • [40] AN OPEN-LABEL EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Morimoto, Kozo
    Castellotti, Paola Francesca
    Yim, Jae-Joon
    Ruoss, Stephen
    van Ingen, Jakko
    Coulter, Christopher
    Mange, Kevin
    Nezamis, James
    Griffith, David
    CHEST, 2019, 156 (04) : 146A - 147A
12345